LVIS

LVIS Corporation is a pioneering neurotechnology company developing products to revolutionize neurological healthcare through rapid and accurate identification of complex neural network patterns. Headquartered in Palo Alto, California, with offices in Seoul and Daegu, South Korea, LVIS leverages over a decade of research led by its founder, Jin Hyung Lee, an Associate Professor at Stanford University, along with exclusive licensing agreements from UCLA and Stanford University.

The company's flagship product, NeuroMatch, is an AI-powered cloud-based SaaS platform that revolutionizes EEG diagnostics by enabling rapid interpretation of brain data in seconds rather than hours. NeuroMatch has received regulatory clearance from both the U.S. FDA and Korea's MFDS, and is deployed in major hospitals across the United States and South Korea. LVIS has been recognized with multiple prestigious grants and fellowships, including the Stanford StartX program, NVIDIA Inception Program, Stanford Byers Center for Biodesign Faculty Fellowship Program, and has received the Stanford Spectrum grant, LIVA NOVA project grant, and Epilepsy Foundation research grant. The company was named a finalist for the 2026 Edison Awards and received the AI Excellence Award for NeuroMatch.